Sugammadex Injection [Bridion]

DRUG4 trials

Sponsors

University Health Network, Toronto, Pusan National University Yangsan Hospital, Erasme University Hospital, National Cancer Institute, Egypt

Conditions

Emergence DeliriumPost-operative Residual CurarizationPosterior Cervical Decompression and FusionTime of a TOF Ratio >0,9

Phase 4

A Randomized Controlled Crossover Study Comparing Sugammadex and Placebo

CompletedNCT03087513

University Health Network, TorontoPosterior Cervical Decompression and Fusion

Start: 2018-02-05End: 2020-04-30Updated: 2020-06-17

Effect of Sugammadex vs. Neostigmine/Glycopyrrolate on Pediatric Emergence Delirium in Sevoflurane-rocuronium Anesthesia

CompletedNCT03229486

Pusan National University Yangsan HospitalEmergence Delirium

Start: 2017-03-01End: 2019-12-30Updated: 2020-03-17

Minimal Optimal Dose of Sugammadex in Elective Surgery

CompletedNCT03515694

Erasme University HospitalTime of a TOF Ratio >0,9

Start: 2018-04-03End: 2018-09-30Updated: 2019-02-15

Different Reversal Agents in Pediatric Day-case Cancer Surgery

National Cancer Institute, EgyptPost-operative Residual Curarization

Start: 2019-06-30End: 2019-10-31Target: 80Updated: 2019-06-25

Related Papers

Effect of reversal of residual neuromuscular blockade on the amplitude of motor evoked potentials: a randomized controlled crossover study comparing sugammadex and placebo.

2021-05-265 citations